NCT04633759

Brief Summary

The Primary Aim of this research study is to determine the feasibility of 8 weeks of physical therapy strengthening exercises using blood flow restriction (BFR) in people with multiple sclerosis (MS) who have moderate-to-severe walking problems. BFR training involves placing a cuff on the leg being exercised in order to restrict blood flow. The cuff is attached to a specialized device that automatically detects the appropriate amount of pressure to place on the limb. Testing will occur before and after the 8-week treatment period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 12, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 18, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

February 19, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 5, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2022

Completed
Last Updated

October 20, 2022

Status Verified

October 1, 2022

Enrollment Period

1.6 years

First QC Date

November 12, 2020

Last Update Submit

October 19, 2022

Conditions

Keywords

Multiple SclerosisBlood Flow RestrictionResistance Training

Outcome Measures

Primary Outcomes (3)

  • Change in knee extension muscle strength

    Knee extension muscle strength measured by hand-held dynamometry

    Measured at Baseline (Week 0) and Post Test (Week 9)

  • Change in hip abduction muscle strength

    Hip abduction muscle strength measured by hand-held dynamometry

    Measured at Baseline (Week 0) and Post Test (Week 9)

  • Change in ankle plantarflexion muscle strength

    Ankle plantarflexion muscle strength measured by hand-held dynamometry

    Measured at Baseline (Week 0) and Post Test (Week 9)

Secondary Outcomes (8)

  • Change in 30-second sit-to-stand completions

    Measured at Baseline (Week 0) and Post Test (Week 9)

  • Change in Berg Balance Scale

    Measured at Baseline (Week 0) and Post Test (Week 9)

  • Change in timed 25-foot walk

    Measured at Baseline (Week 0) and Post Test (Week 9)

  • Change in activity level

    Measured at Baseline (Week 0) and Post Test (Week 9)

  • Change in 12-Item MS Walking Scale

    Measured at Baseline (Week 0) and Post Test (Week 9)

  • +3 more secondary outcomes

Study Arms (1)

Blood Flow Restriction Exercise

EXPERIMENTAL

Participant will participate in a supervised low load blood flow restriction exercise program twice a week for 8 weeks.

Other: Blood Flow Restriction Exercise

Interventions

Following a 5-minute low intensity warm-up, the BFR cuff will be placed at the most proximal portion of the leg and dosed following standard BFR guidelines: 1 set of 30 reps, then 3 sets of 15 reps at 20-30% 1RM with up to 80% limb occlusion. Exercises will target bilateral 1) knee and hip extension, 2) hip abduction, and 3) ankle plantarflexion, as these muscles are important for functional mobility in people with MS.

Blood Flow Restriction Exercise

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ages 18-70
  • Neurologist-confirmed diagnosis of multiple sclerosis
  • Expanded Disability Status Scale (EDSS) 6.0 to 7.0
  • EDSS 6.0: unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting
  • EDSS 6.5: Bilateral assistance (cane or crutch) required to walk at least 20 meters with or without resting
  • EDSS 7.0: unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day

You may not qualify if:

  • EDSS 7.5 or greater: Restricted to wheelchair for all mobility, unable to walk more than a few steps, even with walking aid
  • EDSS 5.5 or less: Able to walk more than 100 meters without walking aid or rest
  • Unable to provide consent or follow simple directions
  • Prior history of Deep Venous Thrombosis/ Pulmonary Embolism
  • History of peripheral vascular disease, thrombophilia or other clotting disorders
  • Patient report of easy bruising
  • Any comorbid conditions or pain that substantially affects physical function or would interfere with the participant's ability to safely complete rehabilitation (e.g. neurologic, vascular, cardiac problems, orthopedic, or ongoing medical treatments) as determined by a neurologist of physical therapist
  • Severe lower extremity spasticity as defined as Modified Ashworth scale \> 2
  • Currently undergoing supervised resistance training with a physical therapist or other exercise professional
  • Use of Blood Flow Restriction currently or in the previous 3 months prior to enrollment
  • MS-related exacerbation or changes to their disease-modifying drug therapy in the month prior to enrollment
  • Inability to tolerate pressure cuff during baseline assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado

Aurora, Colorado, 80045, United States

Location

Related Publications (1)

  • Manago MM, Cohen ET, Cameron MH, Christiansen CL, Bade M. Reliability, Validity, and Responsiveness of the Patient-Specific Functional Scale for Measuring Mobility-Related Goals in People With Multiple Sclerosis. J Neurol Phys Ther. 2023 Jul 1;47(3):139-145. doi: 10.1097/NPT.0000000000000439. Epub 2023 Mar 7.

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

Blood Flow Restriction Therapy

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2020

First Posted

November 18, 2020

Study Start

February 19, 2021

Primary Completion

October 5, 2022

Study Completion

October 5, 2022

Last Updated

October 20, 2022

Record last verified: 2022-10

Locations